◆ NeutralAZN
DaltonTx, the decision engine for drug discovery, launches advanced AI-powered antibody discovery platform
GlobeNewswire Inc.·
DaltonTx announced the launch of advanced antibody discovery capabilities within its Dalton platform, which integrates AI models for antibody design, structure prediction and validation. The platform can evaluate millions of antibody sequences and help researchers identify promising candidates more efficiently by combining AI outputs with experimental data and expert judgment.
Read Full Article at GlobeNewswire Inc. →